{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:37Z","timestamp":1788844237988,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prognostic relevance of early peripheral immune profiles after successful endovascular thrombectomy (EVT) remains incompletely characterized. We evaluated whether associations between lymphocyte-subset percentages and 90-day functional outcome differed according to early post-EVT white blood cell (WBC) count.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included acute anterior-circulation large-vessel occlusion who achieved successful reperfusion (mTICI 2b or 3) after EVT between January 2021 and December 2023. Blood samples obtained within 24 hours after EVT were classified as normal WBC (4.0\u201310.0 \u00d710^9\/L) or elevated WBC (&amp;gt;10.0 \u00d710^9\/L). The primary outcome was unfavorable 90-day functional status (mRS 3\u20136). Prespecified multivariable logistic models adjusted for age, sex, admission NIHSS, ASPECTS, ICA versus MCA occlusion, collateral status, and mTICI grade. Interaction, nonlinear, and sensitivity analyses were also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 334 patients met the eligibility criteria; after excluding one patient without a valid 90-day mRS assessment, 333 patients were included in the primary outcome analysis, including 205 (61.6%) in the normal-WBC group and 128 (38.4%) in the elevated-WBC group. In the normal-WBC group, lower CD19+ B-cell percentage (adjusted odds ratio [aOR] 0.918, 95% CI 0.864\u20130.976; P\u00a0=\u00a00.006) and higher NLR (aOR 1.170, 95% CI 1.043\u20131.311; P\u00a0=\u00a00.007) were associated with unfavorable outcome. In the elevated-WBC group, lower CD3+ T-cell percentage (aOR 0.960, 95% CI 0.926\u20130.995; P\u00a0=\u00a00.026) and lower CD8+ T-cell percentage (aOR 0.943, 95% CI 0.896\u20130.992; P\u00a0=\u00a00.024) were associated with unfavorable outcome. Biomarker-by-WBC interactions were significant for CD19, NLR, CD3, and CD8. Addition of these biomarkers numerically increased AUCs, but paired DeLong comparisons were not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early post-EVT WBC count modified the associations between selected peripheral immune-cell percentages and 90-day functional outcome. These exploratory findings require prospective validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>www.chictr.org.cn<\/jats:ext-link>\n                      , identifier ChiCTR2300070650.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1863605","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:43Z","timestamp":1788841603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of peripheral immunity after thrombectomy in acute ischemic stroke: a retrospective study stratified by early post-EVT leukocyte count"],"prefix":"10.3389","volume":"17","author":[{"given":"Tianfu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhou","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoshan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yijishan Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-015889","article-title":"Predictors of poor clinical outcome despite complete reperfusion in acute ischemic stroke patients","volume":"13","author":"van Horn","year":"2021","journal-title":"J neurointerv Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-017963","article-title":"Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a meta-analysis","volume":"14","author":"Deng","year":"2022","journal-title":"J neurointerv Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018436","article-title":"Successful mechanical thrombectomy in acute ischemic stroke: revascularization grade and functional independence","volume":"14","author":"Ghozy","year":"2022","journal-title":"J neurointerv Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42466-024-00355-y","article-title":"Ischemia\/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments","volume":"6","author":"Stoll","year":"2024","journal-title":"Neurol Res Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00943-7","article-title":"Inflammatory responses after ischemic stroke","volume":"44","author":"DeLong","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential","volume":"130","author":"Iadecola","year":"2020","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110332","article-title":"Neuroinflammation and peripheral immunity: focus on ischemic stroke","volume":"120","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01930-y","article-title":"Systemic immune-inflammation response is associated with futile recanalization after endovascular treatment","volume":"41","author":"Chen","year":"2024","journal-title":"Neurocrit Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.963111","article-title":"Postoperative neutrophil-lymphocyte ratio predicts unfavorable outcome of acute ischemic stroke patients who achieve complete reperfusion after thrombectomy","volume":"13","author":"Feng","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.990209","article-title":"Post-operative neutrophil-to-lymphocyte ratio and outcome after thrombectomy in acute ischemic stroke","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.941251","article-title":"Day 1 neutrophil-to-lymphocyte ratio predicts stroke outcome after intravenous thrombolysis and mechanical thrombectomy","volume":"13","author":"Chen","year":"2022","journal-title":"Front Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1118563","article-title":"Prognostic role of dynamic neutrophil-to-lymphocyte ratio in acute ischemic stroke after reperfusion therapy: a meta-analysis","volume":"14","author":"Wu","year":"2023","journal-title":"Front Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70023","article-title":"Impact of peripheral lymphocyte subsets on prognosis for patients after acute ischemic stroke: a potential disease prediction model approach","volume":"30","author":"Zhou","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000082721.62796.09","article-title":"Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke","volume":"34","author":"Higashida","year":"2003","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-019-00749-0","article-title":"FasL-PDPK1 pathway promotes the cytotoxicity of CD8+ T cells during ischemic stroke","volume":"11","author":"Fan","year":"2020","journal-title":"Transl Stroke Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157678","article-title":"Neuroprotection against ischemic stroke requires a specific class of early responder T cells in mice","volume":"132","author":"Cai","year":"2022","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12975-021-00923-3","article-title":"Natural killer cells are present in Rag1\u2011\/\u2011 mice and promote tissue damage during the acute phase of ischemic stroke","volume":"13","author":"Rolfes","year":"2022","journal-title":"Transl Stroke Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02689-x","article-title":"Brain endothelial CXCL12 attracts protective natural killer cells during ischemic stroke","volume":"20","author":"Wang","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1087815","article-title":"Immune regulation based on sex differences in ischemic stroke pathology","volume":"14","author":"Niu","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3616","article-title":"Dynamic change of neutrophil-to-lymphocyte ratio and its predictive value of prognosis in acute ischemic stroke","volume":"14","author":"Qian","year":"2024","journal-title":"Brain Behav"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911661","article-title":"Systemic immune responses after ischemic stroke: from the center to the periphery","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.671739","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio as a predictor of pneumonia and urinary tract infection within the first week after acute ischemic stroke","volume":"12","author":"Gens","year":"2021","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X21995694","article-title":"Change and predictive ability of circulating immunoregulatory lymphocytes in long-term outcomes of acute ischemic stroke","volume":"41","author":"Li","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.106244","article-title":"Acute ischaemic stroke alters the composition and function of circulating B cells","volume":"133","author":"Younas","year":"2026","journal-title":"Brain Behav Immun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1623-11.2011","article-title":"Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke","volume":"31","author":"Ren","year":"2011","journal-title":"J Neurosci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9413-3","article-title":"IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke","volume":"28","author":"Bodhankar","year":"2013","journal-title":"Metab Brain Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12974-021-02316-7","article-title":"Interleukin-10 improves stroke outcome by controlling the detrimental interleukin-17A response","volume":"18","author":"Piepke","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0626","article-title":"Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke: the MARVEL randomized clinical trial","volume":"331","year":"2024","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00526-2","article-title":"New insights into the cell- and tissue-specificity of glucocorticoid actions","volume":"18","author":"Quatrini","year":"2021","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:44Z","timestamp":1788841604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1863605"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1863605","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1863605"}}